Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to announce that it has received firm commitments from new and existing institutional investors for a non-underwritten placement of 8.6 million new fully paid ordinary shares.
Proteomics International Laboratories Ltd , a pioneer in predictive diagnostics is pleased to announce that it has received firm commitments from new and existing institutional investors for a.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce the signing of a licence agreement to expand PromarkerD s reach in Central and South America.
ASX Health Stocks: Neuren to start Phase 2 trial soon; Proteomics expands footprint in South America stockhead.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockhead.com.au Daily Mail and Mail on Sunday newspapers.
Proteomics International Laboratories Ltd is pleased to announce the signing of a licence agreement to expand PromarkerD s reach in Central and South America. The deal with long-standing partner.